Carteolol: preliminary study on ocular pressure-reducing action.
The authors studied the pressure-reducing action of a new beta-blocking agent (carteolol) in a group of subjects affected with open angle glaucoma. The drug was efficacious in all cases treated and did not show any noteworthy side effects.
D000328:Adult; D000368:Aged; D002354:Carteolol / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000008:administration & dosage*; D013997:Time Factors
D009883:Ophthalmic Solutions; D011412:Propanolamines; D002354:Carteolol